K. Spratt

Early Clinical Experience of CD19 x CD22 Dual Specific CAR T Cells for Enhanced Anti-Leukemic Targeting of Acute Lymphoblastic Leukemia

M. Jensen, Lauren A Huang, O. Finney, 2018, Blood.

Novel CD19t T-Antigen Presenting Cells Expand CD19 CAR T Cells In Vivo

M. Jensen, Julie R. Park, Colleen Annesley, 2019, Blood.

Prolonged functional persistence of CD19CAR t cell products of defined CD4:CD8 composition and transgene expression determines durability of MRD-negative ALL remission.

A. Oron, M. Jensen, O. Finney, 2016 .